Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: Comparison of the results of two individual case reviews performed early and late during the accrual period

Radiotherapy and Oncology

Volumn 76, Issue 3, 2005, Pages 278-284

  Poortmans, Philip M P ^a   Ataman, Fatma ^b   Davis, Jacques Bernard ^c   Bartelink, Harry ^d   Horiot, Jean Claude ^e   Pierart, Marianne ^b   Collette, Laurence ^b   Van Tienhoven, Geertjan ^f  

^a DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e CENTRE GEORGES FRANÇOIS LECLERC   (France)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Breast conserving therapy; Individual case review; Quality assurance; Radiotherapy; Randomised clinical trial

Indexed keywords

BREAST CARCINOMA; CANCER CENTER; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FOLLOW UP; HUMAN; MEDICAL RECORD; MULTICENTER STUDY; PATHOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RADIATION DOSE; REVIEW; TREATMENT OUTCOME;

EID: 25844507604     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.04.001     Document Type: Article

References (30)

1. R. Arriagada, M.G. Le, F. Rochard, and G. Contesso Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave Roussy Breast Cancer Group J Clin Oncol 14 1996 1558 1564
2. H. Bartelink, J.C. Horiot, and P. Poortmans Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 2001 1378 1387
3. Bartelink H, Horiot JC, van der Schueren E. Phase III study in the conservative management of breast carcinoma by tumorectomy and radiotherapy: assessment of the role of a booster dose of radiotherapy. Protocol 22881/10882. Brussels, Belgium: EORTC Radiotherapy Cooperative Group EORTC Data Center, 1998.
4. T.A. Bucholtz, E. Gurgose, E.S. Bice, and B.R. Prestidge Dosimetric analysis of intact breast irradiation in off-axis planes Int J Radiat Oncol Biol Phys 39 1997 261 267
5. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and surgery in early breast cancer: an overview of randomised trials N Engl Med 333 1995 1444 1455
6. B. Fisher, S. Anderson, C.K. Redmond, N. Wolmark, D.L. Wickerham, and W.M. Cronin Reanalysis and results after 12 years of follow-up in a randomised clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer N Engl J Med 333 1995 1456 1461
7. I. Gage, A. Recht, and R. Gelman Long-term outcome following breast-conserving surgery and radiation therapy Int J Radiat Oncol Biol Phys 33 1995 245 251
8. H.P. Hamers, K.A. Johansson, J.L. Venselaar, P. de Brouwer, U. Hansson, and C. Moudi Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-Radiotherapy Cooperative Group Radiother Oncol 22 1991 280 284
9. H.P. Hamers, K.A. Johansson, J.L. Venselaar, P. de Brouwer, U. Hansson, and C. Moudi In vivo dosimetry with TLD in conservative treatment of breast cancer patients treated with the EORTC protocol 22881 Acta Oncol 32 1993 435 443
10. U. Hansson, and K.A. Johansson Quality audit of radiotherapy with EORTC mailed in water TL-dosimetry Radiother Oncol 20 1991 191 196
11. S. Heukelom, J.H. Lanson, G. van Tienhoven, and B.J. Mijnheer In vivo dosimetry during tangential breast treatment Radiother Oncol 22 1991 269 279
12. J.C. Horiot, K.A. Johansson, D.G. Gonzalez, E. van der Schueren, W. van den Bogaert, and G. Notter Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment Radiother Oncol 6 1986 274 284
13. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Unit and Measurements, 7910 Woodmont Avenue, Bethseda, MD 20814, USA.
14. J.A. Jacobson, D.N. Danforth, and K.H. Cowan Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer N Engl J Med 332 1995 907 911
15. K.A. Johansson, J.C. Horiot, J. Van Dam, D. Lepinoy, I. Sentenac, and G. Sernbo Quality assurance control. 2. Dosimetric intercomparison Radiother Oncol 7 1986 269 279
16. K.A. Johansson, J.C. Horiot, and E. van der Schueren Quality assurance control in the EORTC cooperative group of radiotherapy. 3. Intercomparison in an anatomical phantom Radiother Oncol 9 1987 289 298
17. M. Krasin, A. McCall, S. King, M. Olson, and B. Emami Evaluation of standard breast irradiation technique: A dose-volume analysis of tangential irradiation using three dimensional tools Int J Radiat Oncol Biol Phys 47 2000 327 333
18. P. Poortmans, H. Bartelink, and J.C. Horiot The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial Radiother Oncol 72 2004 25 33
19. P. Poortmans, V.E. Kouloulias, and J.L. Venselaar Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review Eur J Cancer 39 2003 2035 2042
20. D. Sarrazin, M.G. Le, and R. Arriagada Ten-year results of a randomised trial comparing a conservative treatment to mastectomy in early breast cancer Radiother Oncol 14 1989 177 184
21. E. Touboul, L. Buffat, and Y. Belkacemi Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer Int J Radiat Oncol Biol Phys 43 1999 25 38
22. N.A. Van Bree, L.J. van Battum, H. Huizenga, and B.J. Mijnheer Three-dimensional dose distribution of tangential breast treatment: a national dosimetry intercomparison Radiother Oncol 22 1991 252 260
23. J.A. Van Dongen, A.C. Voogd, and I.S. Fentiman Long-term results of a randomised trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial J Natl Cancer Inst 92 2000 1143 1150
24. G. Van Tienhoven, J.H. Lanson, D. Crabeels, S. Heukelom, and B.J. Mijnheer Accuracy in tangential breast treatment set-up: a portal imaging study Radiother Oncol 22 1991 317 322
25. G. Van Tienhoven, B.J. Mijnheer, H. Bartelink, and D.G. Gonzalez Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview Strahlenther Oncol 173 1997 201 207
26. G. Van Tienhoven, N.A.M. Van Bree, B. Mijnheer, and H. Bartelink Quality assurance of the EORTC trial 22881/10882: 'assessment of the role of the booster dose in breast conserving therapy': the Dummy Run. EORTC Radiotherapy cooperative group Radiother Oncol 22 1991 290 298
27. K. Vantongelen, N. Rotmensz, and E. van der Schueren Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM) Eur J Cancer Clin Oncol 25 1989 1241 1247
28. U. Veronesi, A. Banfi, and B. Salvadori Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial Eur J Cancer 26 1990 668 670
29. U. Veronesi, B. Salvadori, and A. Luini Breast conservation is a safe method in patients with small cancer of the breast: long-term results of three randomised trials on 1973 patients Eur J Cancer 31 1995 1574 1579
30. C. Vrieling, L. Collette, and A. Fourquet The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC 'boost versus no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer Int J Radiat Oncol Biol Phys 45 1999 677 685